Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Endoclips versus heater probe in preventing early recurrent bleeding from peptic ulcer: a prospective and randomized trial
Autore:
Cipolletta, L; Bianco, MA; Marmo, R; Rotondano, G; Piscopo, R; Vingiani, AM; Meucci, C;
Indirizzi:
Maresca Hosp, Dept Gastroenterol & Endoscopy, Torro Del Greco, Naples, Italy Maresca Hosp Torro Del Greco Naples Italy Torro Del Greco, Naples, Italy
Titolo Testata:
GASTROINTESTINAL ENDOSCOPY
fascicolo: 2, volume: 53, anno: 2001,
pagine: 147 - 151
SICI:
0016-5107(200102)53:2<147:EVHPIP>2.0.ZU;2-D
Fonte:
ISI
Lingua:
ENG
Soggetto:
ENDOSCOPIC INJECTION THERAPY; NONBLEEDING VISIBLE VESSEL; ETHANOL INJECTION; HEMORRHAGE; HEMOSTASIS; HEMOCLIP; EFFICACY; THERMOCOAGULATION; METAANALYSIS;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
27
Recensione:
Indirizzi per estratti:
Indirizzo: Cipolletta, L Via S Domenico Al Vomero 24, I-80126 Naples, Italy Via S Domenico Al Vomero 24 Naples Italy I-80126 es, Italy
Citazione:
L. Cipolletta et al., "Endoclips versus heater probe in preventing early recurrent bleeding from peptic ulcer: a prospective and randomized trial", GASTROIN EN, 53(2), 2001, pp. 147-151

Abstract

Background: Endoscopic application of hemoclips (HC) was prospectively compared with heat probe (HP) treatment in patients with bleeding ulcers. Methods: One hundred thirteen patients with major stigmata of ulcer hemorrhage were randomly assigned to receive HP (n = 57) or HC (n = 56). Clinicaland endoscopic features were comparable in both groups. Recurrent bleedingwas retreated with the modality previously used. Patients in whom treatment or retreatment was unsuccessful underwent emergency surgery. Results: Hemostasis, adequate treatment of visible vessel, 30-day mortality, and emergency surgery rates were similar for both groups. Recurrent bleeding was 21% for HP and 1.8% for HC (p < 0.05). Length of hospital stay andtransfusion requirements were significantly lower in the HC group. There was no evidence of clip-induced tissue injury or impaired ulcer healing. Clips dislodged spontaneously in most patients within 8 weeks of treatment. Nofurther hemorrhage occurred on a median follow-up of 11 months (range 1-23). Conclusions: The hemoclip is safe and effective in the treatment of severeulcer bleeding and is superior to HP in preventing early recurrent bleeding.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 21:48:31